Advertisement
Original Article| Volume 111, P5-12, October 2020

Characterization of Severe and Extreme Behavioral Problems in Patients With Alternating Hemiplegia of Childhood

  • Keri Wallace
    Affiliations
    Division of Pediatric Neurology and Developmental Medicine, Duke Children’s Health Center, Durham, North Carolina
    Search for articles by this author
  • Author Footnotes
    1 Present address: Department of Pediatrics, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
    Julie Uchitel
    Footnotes
    1 Present address: Department of Pediatrics, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
    Affiliations
    Division of Pediatric Neurology and Developmental Medicine, Duke Children’s Health Center, Durham, North Carolina
    Search for articles by this author
  • Lyndsey Prange
    Affiliations
    Division of Pediatric Neurology and Developmental Medicine, Duke Children’s Health Center, Durham, North Carolina
    Search for articles by this author
  • Joan Jasien
    Affiliations
    Division of Pediatric Neurology and Developmental Medicine, Duke Children’s Health Center, Durham, North Carolina
    Search for articles by this author
  • Melanie Bonner
    Affiliations
    Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina
    Search for articles by this author
  • Author Footnotes
    2 Present address: Department of Psychiatry, McKnight Brain Institute, University of Florida, Gainesville, Florida.
    Richard D’Alli
    Footnotes
    2 Present address: Department of Psychiatry, McKnight Brain Institute, University of Florida, Gainesville, Florida.
    Affiliations
    Division of Child Development and Behavioral Health, Department of Pediatrics, Duke University, Durham, North Carolina
    Search for articles by this author
  • Gary Maslow
    Affiliations
    Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina

    Department of Pediatrics, Duke University, Durham, North Carolina
    Search for articles by this author
  • Mohamad A. Mikati
    Correspondence
    Communications should be addressed to: Dr. Mikati; Division of Pediatric Neurology and Developmental Medicine; Duke University Medical Center; DUMC 3936; Durham, NC 27710.
    Affiliations
    Division of Pediatric Neurology and Developmental Medicine, Duke Children’s Health Center, Durham, North Carolina
    Search for articles by this author
  • Author Footnotes
    1 Present address: Department of Pediatrics, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
    2 Present address: Department of Psychiatry, McKnight Brain Institute, University of Florida, Gainesville, Florida.

      Abstract

      Background

      Alternating hemiplegia of childhood often manifests severe or extreme behavioral problems, the nature of which remains to be fully characterized.

      Methods

      We analyzed 39 consecutive patients with alternating hemiplegia of childhood for occurrence of behavioral problems and categorized those by severity: mild (not requiring intervention), moderate (requiring intervention but no risk), severe (minor risk to self, others, or both), and extreme (major risk). We then analyzed behavioral manifestations, concurrent morbidity, and medication responses in patients with severe or extreme symptoms.

      Results

      Two patients had mild behavioral problems, five moderate, 10 severe, six extreme, and 16 none. Extreme cases exhibited disruptive behaviors escalating to assaults. Triggers, when present, included peer-provocation, low frustration tolerance, limits set by others, and sleep disruption. Reversible psychotic symptoms occurred in two patients: in one triggered by infection and trihexyphenidyl, and in another triggered by sertraline. Of the 16 patients with severe or extreme symptoms, 13 had concurrent neuropsychiatric diagnoses. Occurrence of severe or extreme symptoms did not correlate with age, puberty, severity of intellectual disability, or mutation status (P > 0.05). A multidisciplinary team including mental health professionals comanaged all patients with severe or extreme symptoms with either behavioral therapy, medications, or both. When considering medications prescribed to more than four patients, medicines that demonstrated efficacy or partial efficacy in more than 50% of patients were alpha-adrenergic agonists and selective-serotonin-reuptake-inhibitors.

      Conclusions

      Patients with alternating hemiplegia of childhood (41%) often experience severe or extreme behavioral problems and, rarely, medication-triggered psychotic symptoms. These observations are consistent with current understanding of underlying alternating hemiplegia of childhood brain pathophysiology. Increasing awareness of these behavioral problems facilitates alternating hemiplegia of childhood management and anticipatory guidance.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Pediatric Neurology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Heinzen E.L.
        • Swoboda K.J.
        • Hitomi Y.
        • et al.
        De novo mutations in ATP1A3 cause alternating hemiplegia of childhood.
        Nat Genet. 2012; 44: 1030-1034
        • Mikati M.A.
        • Kramer U.
        • Zupanc M.L.
        • Shanahan R.J.
        Alternating hemiplegia of childhood: clinical manifestations and long-term outcome.
        Pediatr Neurol. 2000; 23: 134-141
        • Panagiotakaki E.
        • Gobbi G.
        • Neville B.
        • et al.
        Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults.
        Brain. 2010; 133: 3598-3610
        • Jasien J.M.
        • Bonner M.
        • D’alli R.
        • et al.
        Cognitive, adaptive, and behavioral profiles and management of alternating hemiplegia of childhood.
        Dev Med Child Neurol. 2019; 61: 547-554
        • Uchitel J.
        • Abdelnour E.
        • Boggs A.
        • et al.
        Social impairments in alternating hemiplegia of childhood.
        Dev Med Child Neurol. 2020; 62: 820-826
        • Bøttger P.
        • Tracz Z.
        • Heuck A.
        • Nissen P.
        • Romero-Ramos M.
        • Lykke-Hartmann K.
        Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain.
        J Comp Neurol. 2011; 519: 376-404
        • Chu Y.
        • Parada I.
        • Prince D.A.
        Temporal and topographic alterations in expression of the α3 isoform of Na+, K+-ATPase in the rat freeze lesion model of microgyria and epileptogenesis.
        Neuroscience. 2009; 162: 339-348
        • Hunanyan A.S.
        • Helseth A.R.
        • Abdelnour E.
        • et al.
        Mechanisms of increased hippocampal excitability in the Mashl+/- mouse model of Na+/K+-ATPase dysfunction.
        Epilepsia. 2018; 59: 1455-1468
        • Richards K.S.
        • Bommert K.
        • Szabo G.
        • Miles R.
        Differential expression of Na+/K+-ATPase α-subunits in mouse hippocampal interneurones and pyramidal cells.
        J Physiol. 2007; 585: 491-505
        • Goldstein I.
        • Lerer E.
        • Laiba E.
        • et al.
        Association between sodium- and potassium-activated adenosine triphosphatase alpha isoforms and bipolar disorders.
        Biol Psychiatry. 2009; 65: 985-991
        • Fernandes C.
        • Mikati M.A.
        The expanding spectrum of ATP1A3 related disease.
        Eur J Paediatr Neurol. 2019; 23: 345-346
        • Mynett-Johnson L.
        • Murphy V.
        • McCormack J.
        • et al.
        Evidence for an allelic association between bipolar disorder and a Na+, K+ adenosine triphosphatase alpha subunit gene (ATP1A3).
        Biol Psychiatry. 1998; 44: 47-51
        • Smedemark-Margulies N.
        • Brownstein C.A.
        • Vargas S.
        • et al.
        A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
        Cold Spring Harb Mol Case Stud. 2016; 2: a001008
        • Kirshenbaum G.S.
        • Saltzman K.
        • Rose B.
        • Petersen J.
        • Vilsen B.
        • Roder J.C.
        Decreased neuronal Na+, K+-ATPase activity in ATP1A3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress.
        Genes Brain Behav. 2011; 10: 542-550
        • Helseth A.R.
        • Hunanyan A.S.
        • Adil S.
        • et al.
        Novel E815K knock-in mouse model of alternating hemiplegia of childhood.
        Neurobiol Dis. 2018; 119: 100-112
        • Hunanyan A.S.
        • Fainberg N.A.
        • Linabarger M.
        • et al.
        Knock-in mouse model of alternating hemiplegia of childhood: behavioral and electrophysiologic characterization.
        Epilepsia. 2015; 56: 82-93
        • Maskey M.
        • Warnell F.
        • Parr J.R.
        • Le Couteur A.
        • McConachie H.
        Emotional and behavioural problems in children with autism spectrum disorder.
        J Autism Dev Disord. 2013; 43: 851-859
        • McGuire K.
        • Fung L.K.
        • Hagopian L.
        • et al.
        Irritability and problem behavior in autism spectrum disorder: a practice pathway for pediatric primary care.
        Pediatrics. 2016; 137: S136-S148
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        5th ed. American Psychiatric Association, Washington, DC2013
        • Achenbach T.M.
        • Edelbrock C.S.
        The classification of child psychopathology: a review and analysis of empirical efforts.
        Psychol Bull. 1978; 85: 1275-1301
        • Regier D.A.
        • Kuhl E.A.
        • Kupfer D.J.
        The DSM-5: classification and criteria changes.
        World Psychiatry. 2013; 12: 92-98
        • Turygin N.C.
        • Matson J.L.
        • Adams H.
        • Belva B.
        The effect of DSM-5 criteria on externalizing, internalizing, behavioral and adaptive symptoms in children diagnosed with autism.
        Dev Neurorehabil. 2013; 16: 277-282
        • Masoud M.
        • Prange L.
        • Wuchich J.
        • Hunanyan A.
        • Mikati M.A.
        Diagnosis and treatment of alternating hemiplegia of childhood.
        Curr Treat Options Neurol. 2017; 19: 8
        • Uchitel J.
        • Helseth A.
        • Prange L.
        • et al.
        The epileptology of alternating hemiplegia of childhood.
        Neurology. 2019; 93: e1248-e1259
        • Katz G.
        • Lazcano-Ponce E.
        Intellectual disability: definition, etiological factors, classification, diagnosis, treatment and prognosis.
        Salud Publica Mex. 2008; 50: s132-s141
        • Constantino J.N.
        • Gruber C.P.
        Social Responsiveness Scale (SRS) Manual.
        Western Psychological Services, Los Angeles, CA2005
        • Kwan P.
        • Arzimanoglou A.
        • Berg A.T.
        • et al.
        Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.
        Epilepsia. 2010; 51 ([published correction appears in Epilepsia. 2010;51:1922]): 1069-1077
        • Sukhodolsky D.G.
        • Smith S.D.
        • McCauley S.A.
        • Ibrahim K.
        • Piasecka J.B.
        Behavioral interventions for anger, irritability, and aggression in children and adolescents.
        J Child Adolesc Psychopharmacol. 2016; 26: 58-64
        • Kaartinen M.
        • Puura K.
        • Helminen M.
        • Salmelin R.
        • Pelkonen E.
        • Juujärvi P.
        Reactive aggression among children with and without autism spectrum disorder.
        J Autism Dev Disord. 2014; 44 ([published correction appears in J Autism Dev Disord. 2017;47:1923-1924]): 2383-2391
        • Perepletchikova F.
        • Nathanson D.
        • Axelrod S.R.
        • et al.
        Randomized clinical trial of dialectical behavior therapy for preadolescent children with disruptive mood dysregulation disorder: feasibility and outcomes.
        J Am Acad Child Adolesc Psychiatry. 2017; 56: 832-840
        • Spielman G.M.
        Clinical studies in behavior therapy with children, adolescents and their families.
        Pediatr Ann. 1974; 3: 79-80
        • Wolraich M.L.
        Behavior modification therapy in hyperactive children. Research and clinical implications.
        Clin Pediatr (Phila). 1979; 18: 563-570
        • Willner C.J.
        • Gatzke-Kopp L.M.
        • Bray B.C.
        The dynamics of internalizing and externalizing comorbidity across the early school years.
        Dev Psychopathol. 2016; 28: 1033-1052
        • Ollendick T.H.
        • King N.J.
        Diagnosis, assessment, and treatment of internalizing problems in children: the role of longitudinal data.
        J Consult Clin Psychol. 1994; 62: 918-927
        • McMahon R.J.
        Diagnosis, assessment, and treatment of externalizing problems in children: the role of longitudinal data.
        J Consult Clin Psychol. 1994; 62: 901-917
        • Mannuzza S.
        • Klein R.G.
        • Konig P.H.
        • Giampino T.L.
        Hyperactive boys almost grown up. IV. Criminality and its relationship to psychiatric status.
        Arch Gen Psychiatry. 1989; 46: 1073-1079
        • Liu J.
        • Chen X.
        • Lewis G.
        Childhood internalizing behaviour: analysis and implications.
        J Psychiatr Ment Health Nurs. 2011; 18: 884-894
        • Farrington D.P.
        Key issues in studying the biosocial bases of violence.
        in: Nato ASI Series. 292. Springer, Boston, MA1997
        • Gurnani T.
        • Ivanov I.
        • Newcorn J.H.
        Pharmacotherapy of aggression in child and adolescent psychiatric disorders.
        J Child Adolesc Psychopharmacol. 2016; 26: 65-73
        • Hazell P.L.
        • Stuart J.E.
        A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children.
        J Am Acad Child Adolesc Psychiatry. 2003; 42: 886-894
        • Scahill L.
        • McCracken J.T.
        • King B.H.
        • et al.
        Extended-release guanfacine for hyperactivity in children with autism spectrum disorder.
        Am J Psychiatry. 2015; 172: 1197-1206
        • Huss M.
        • Dirks B.
        • Gu J.
        • Robertson B.
        • Newcorn J.H.
        • Ramos-Quiroga J.A.
        Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD.
        Eur Child Adolesc Psychiatry. 2018; 27: 1283-1294
        • Stepanova E.
        • Dowling S.
        • Phelps M.
        • Findling R.L.
        Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents.
        Dialogues Clin Neurosci. 2017; 19: 395-402
        • Rillich J.
        • Stevenson P.A.
        Serotonin mediates depression of aggression after acute and chronic social defeat stress in a model insect.
        Front Behav Neurosci. 2018; 12: 233
        • Vartiainen H.
        • Tiihonen J.
        • Putkonen A.
        • et al.
        Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia.
        Acta Psychiatr Scand. 1995; 91: 348-351
        • Coccaro E.F.
        • Kavoussi R.J.
        Fluoxetine and impulsive aggressive behavior in personality-disordered subjects.
        Arch Gen Psychiatry. 1997; 54: 1081-1088
        • Kirshenbaum G.S.
        • Clapcote S.J.
        • Duffy S.
        • et al.
        Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase α3 sodium pump.
        Proc Natl Acad Sci US A. 2011; 108 ([published correction appears in Proc Natl Acad Sci U S A. 2012;109:2174]): 18144-18149
        • DeLong R.
        Lithium treatment and bipolar disorders in childhood.
        N C Med J. 1990; 51: 152-154
        • Kaprinis S.
        • Parlapani E.
        • Raikos N.
        • Goulas A.
        • Karpouza V.
        Psychotic episode associated with sertraline and drug-related delirium: a case report.
        J Clin Psychopharmacol. 2014; 34: 527-529
        • Popli A.P.
        • Fuller M.A.
        • Jaskiw G.E.
        Sertraline and psychotic symptoms: a case series.
        Ann Clin Psychiatry. 1997; 9: 15-17
        • Trend P.
        • Trimble M.
        • Wessely S.
        Schizophrenic psychosis associated with benzhexol (artane) therapy.
        J Neurol Neurosurg Psychiatry. 1989; 52: 1115
        • Bolin R.R.
        Psychiatric manifestations of artane toxicity case report illustrating the effect of trihexyphenidyl on affective state and personality functioning.
        J Nerv Ment Dis. 1960; 131: 256-259
        • Panes A.
        • Fourrier-Réglat A.
        • Verdoux H.
        • Tournier M.
        Use and misuse of benzodiazepines in patients with psychiatric disorders.
        Presse Med. 2018; 47: 886-891
        • Chen B.
        • Choi H.
        • Hirsch L.J.
        • et al.
        Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
        Epilepsy Behav. 2017; 76: 24-31
        • Mikati M.A.
        • Maguire H.
        • Barlow C.F.
        • et al.
        A syndrome of autosomal dominant alternating hemiplegia: clinical presentation mimicking intractable epilepsy; chromosomal studies; and physiologic investigations.
        Neurology. 1992; 42: 2251-2257
        • Sorge F.
        • De Simone R.
        • Marano E.
        • Nolano M.
        • Orefice G.
        • Carrieri P.
        Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.
        Cephalalgia. 1988; 8: 1-6
        • Rugino T.A.
        • Janvier Y.M.
        Aripiprazole in children and adolescents: clinical experience.
        J Child Neurol. 2005; 20: 603-610
        • Bourgeois M.
        • Aicardi J.
        • Goutières F.
        Alternating hemiplegia of childhood.
        J Pediatr. 1993; 122: 673-679
        • Panagiotakaki E.
        • De Grandis E.
        • Stagnaro M.
        • et al.
        Clinical profile of patients with ATP1A3 mutations in alternating hemiplegia of childhood—a study of 155 patients.
        Orphanet J Rare Dis. 2015; 10: 123
        • Bangerter A.
        • Chatterjee M.
        • Manyakov N.V.
        • et al.
        Relationship between sleep and behavior in autism spectrum disorder: exploring the impact of sleep variability.
        Front Neurosci. 2020; 14: 211
        • Kingsley K.
        • Sagester G.
        • Weaver L.L.
        Interventions supporting mental health and positive behavior in children ages birth-5 yr: a systematic review.
        Am J Occup Ther. 2020; 74 (7402180050p1-7402180050p29)
        • Kansagra S.
        • Ghusayni R.
        • Kherallah B.
        • et al.
        Polysomnography findings and sleep disorders in children with alternating hemiplegia of childhood.
        J Clin Sleep Med. 2019; 15: 65-70
        • Rapoport M.
        • van Reekum R.
        • Mayberg H.
        The role of the cerebellum in cognition and behavior: a selective review.
        J Neuropsychiatry Clin Neurosci. 2000; 12: 193-198
        • Masoud M.
        • Gordon K.
        • Hall A.
        • et al.
        Motor function domains in alternating hemiplegia of childhood.
        Dev Med Child Neurol. 2017; 59: 822-828
        • Sasaki M.
        • Sakuma H.
        • Fukushima A.
        • Yamada K.
        • Ohnishi T.
        • Matsuda H.
        Abnormal cerebral glucose metabolism in alternating hemiplegia of childhood.
        Brain Dev. 2009; 31: 20-26